|
1
|
Banerjee SK, Mukherjee PK and Maulik SK:
Garlic as an antioxidant: The good, the bad and the ugly.
Phytotherapy research. PTR. 17:97–106. 2003.PubMed/NCBI
|
|
2
|
Kyo E, Uda N, Kasuga S and Itakura Y:
Immunomodulatory effects of aged garlic extract. J Nutr. 131 (Suppl
3):1075S–1079S. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fratianni F, Riccardi R, Spigno P, Ombra
MN, Cozzolino A, Tremonte P, Coppola R and Nazzaro F: Biochemical
Characterization and Antimicrobial and Antifungal Activity of Two
Endemic Varieties of Garlic (Allium sativum L.) of the
Campania Region, Southern Italy. J Med Food. 19:686–691. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiao D, Pinto JT, Soh JW, Deguchi A,
Gundersen GG, Palazzo AF, Yoon JT, Shirin H and Weinstein IB:
Induction of apoptosis by the garlic-derived compound
S-allylmercaptocysteine (SAMC) is associated with
microtubule depolymerization and c-Jun NH(2)-terminal kinase 1
activation. Cancer Res. 63:6825–6837. 2003.PubMed/NCBI
|
|
5
|
Ghyasi R, Mohaddes G and Naderi R:
Combination effect of voluntary exercise and garlic (Allium
sativum) on oxidative stress, cholesterol level and
histopathology of heart tissue in type 1 diabetic rats. J
Cardiovasc Thorac Res. 11:61–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
García-Villalón AL, Amor S, Monge L,
Fernández N, Prodanov M, Muñoz M, Inarejos-García AM and Granado M:
In vitro studies of an aged black garlic extract enriched in
S-allylcysteine and polyphenols with cardioprotective
effects. J Funct Foods. 27:189–200. 2016. View Article : Google Scholar
|
|
7
|
Tsai JC, Chen YA, Wu JT, Cheng KC, Lai PS,
Liu KF, Lin YK, Huang YT and Hsieh CW: Extracts from Fermented
Black Garlic Exhibit a Hepatoprotective Effect on Acute Hepatic
Injury. Molecules. 24(pii): E11122019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu ZR, Peng-Chen, Yang-Li, Li JY,
Xin-Wang, Yong-Wang, Guo DD, Lei-Cui, Guan QG and Li HY: Two
cinnamoyloctopamine antioxidants from garlic skin attenuates
oxidative stress and liver pathology in rats with non-alcoholic
steatohepatitis. Phytomedicine. 22:178–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao J, Xing F, Liu Y, Lv Y, Wang X, Ling
M-T, Gao H, Ouyang S, Yang M, Zhu J, et al: Garlic-derived compound
S-allylmercaptocysteine inhibits hepatocarcinogenesis
through targeting LRP6/Wnt pathway. Acta Pharm Sin B. 8:575–586.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panyod S, Wu WK, Ho CT, Lu KH, Liu CT, Chu
YL, Lai YS, Chen WC, Lin YE, Lin SH and Sheen LY: Diet
Supplementation with Allicin Protects against Alcoholic Fatty Liver
Disease in Mice by Improving Anti-inflammation and Antioxidative
Functions. J Agric Food Chem. 64:7104–7113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Starley BQ, Calcagno CJ and Harrison SA:
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A
weighty connection. Hepatology. 51:1820–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong SW, Ting YW and Chan WK: Epidemiology
of non-alcoholic fatty liver disease-related hepatocellular
carcinoma and its implications. JGH Open. 2:235–241. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin XY, Tatsukawa H, Hitomi K, Shirakami
Y, Ishibashi N, Shimizu M, Moriwaki H and Kojima S: Metabolome
Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on
Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic
Tumorigenesis Model. Cancer Prev Res (Phila). 9:205–214. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin XY, Suzuki H, Honda M, Okada H, Kaneko
S, Inoue I, Ebisui E, Hashimoto K, Carninci P, Kanki K, et al:
Prevention of hepatocellular carcinoma by targeting MYCN-positive
liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci
USA. 115:4969–4974. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tatsukawa H, Fukaya Y, Frampton G,
Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K,
Okuno M, Wu J, et al: Role of transglutaminase 2 in liver injury
via cross-linking and silencing of transcription factor Sp1.
Gastroenterology. 136:1783–1795.e10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shrestha R, Shrestha R, Qin XY, Kuo TF,
Oshima Y, Iwatani S, Teraoka R, Fujii K, Hara M, Li M, et al:
Fungus-derived hydroxyl radicals kill hepatic cells by enhancing
nuclear transglutaminase. Sci Rep. 7:47462017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin XY, Lu J, Cai M and Kojima S:
Arachidonic acid suppresses hepatic cell growth through
ROS-mediated activation of transglutaminase. FEBS Open Bio.
8:1703–1710. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujise K, Nagamori S, Hasumura S, Homma S,
Sujino H, Matsuura T, Shimizu K, Niiya M, Kameda H, Fujita K, et
al: Integration of hepatitis B virus DNA into cells of six
established human hepatocellular carcinoma cell lines.
Hepatogastroenterology. 37:457–460. 1990.PubMed/NCBI
|
|
19
|
Qin XY, Wei F, Tanokura M, Ishibashi N,
Shimizu M, Moriwaki H and Kojima S: The effect of acyclic retinoid
on the metabolomic profiles of hepatocytes and hepatocellular
carcinoma cells. PLoS One. 8:e828602013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rose P, Moore PK and Zhu YZ: Garlic and
Gaseous Mediators. Trends Pharmacol Sci. 39:624–634. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colín-González AL, Santana RA, Silva-Islas
CA, Chánez-Cárdenas ME, Santamaria A and Maldonado PD: The
antioxidant mechanisms underlying the aged garlic extract- and
S-allylcysteine-induced protection. Oxid Med Cell Longev.
2012:9071622012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kodai S, Takemura S, Minamiyama Y, Hai S,
Yamamoto S, Kubo S, Yoshida Y, Niki E, Okada S, Hirohashi K, et al:
S-allyl cysteine prevents CCl(4)-induced acute liver injury
in rats. Free Radic Res. 41:489–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eyster KM: The membrane and lipids as
integral participants in signal transduction: Lipid signal
transduction for the non-lipid biochemist. Adv Physiol Educ.
31:5–16. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin XY, Dohmae N and Kojima S: Reply to
Yoshida: Liver cancer stem cells: Identification and lipid
metabolic reprogramming. Proc Natl Acad Sci USA. 115:E6390–E6391.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen L, Ren J, Yang L, Li Y, Fu J, Li Y,
Tian Y, Qiu F, Liu Z and Qiu Y: Stearoyl-CoA desaturase-1 mediated
cell apoptosis in colorectal cancer by promoting ceramide
synthesis. Sci Rep. 6:196652016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lounis MA, Escoula Q, Veillette C,
Bergeron KF, Ntambi JM and Mounier C: SCD1 deficiency protects mice
against ethanol-induced liver injury. Biochim Biophys Acta.
1861:1662–1670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurikawa N, Takagi T, Wakimoto S, Uto Y,
Terashima H, Kono K, Ogata T and Ohsumi J: A novel inhibitor of
stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation,
liver injury and inflammation in model of nonalcoholic
steatohepatitis. Biol Pharm Bull. 36:259–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nardacci R, Lo Iacono O, Ciccosanti F,
Falasca L, Addesso M, Amendola A, Antonucci G, Craxì A, Fimia GM,
Iadevaia V, et al: Transglutaminase type II plays a protective role
in hepatic injury. Am J Pathol. 162:1293–1303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Piacentini M, Baiocchini A, Del Nonno F,
Melino G, Barlev NA, Rossin F, D'Eletto M and Falasca L:
Non-alcoholic fatty liver disease severity is modulated by
transglutaminase type 2. Cell Death Dis. 9:2572018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tatsukawa H, Furutani Y, Hitomi K and
Kojima S: Transglutaminase 2 has opposing roles in the regulation
of cellular functions as well as cell growth and death. Cell Death
Dis. 7:e22442016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shrestha R, Tatsukawa H, Shrestha R,
Ishibashi N, Matsuura T, Kagechika H, Kose S, Hitomi K, Imamoto N
and Kojima S: Molecular mechanism by which acyclic retinoid induces
nuclear localization of transglutaminase 2 in human hepatocellular
carcinoma cells. Cell Death Dis. 6:e20022015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Condello S, Thomes-Pepin J, Ma X,
Xia Y, Hurley TD, Matei D and Cheng JX: Lipid Desaturation Is a
Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem
Cells. Cell Stem Cell. 20:303–314.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma C, Kesarwala AH, Eggert T,
Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor
V, ElGindi M, et al: NAFLD causes selective CD4(+) T lymphocyte
loss and promotes hepatocarcinogenesis. Nature. 531:253–257. 2016.
View Article : Google Scholar : PubMed/NCBI
|
